Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in sequence selective minor groove DNA effectors.

B S Reddy1, S K Sharma, J W Lown

  • 1Department of Chemistry, University of Alberta, Edmonton, AB, QLD 4072, Canada.

Current Medicinal Chemistry
|April 3, 2001
PubMed
Summary

Researchers are developing novel DNA-binding agents for cancer therapy and molecular biology. These sequence-selective compounds, including lexitropsins and PBD dimers, show potent anticancer activity and promise for diagnostics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and evaluation of Fusarium wilt-resistant and high-yielding chickpea advanced breeding line, KCD 11.

The plant genome·2024
Same author

Knowledge extraction of sonophotocatalytic treatment for acid blue 113 dye removal by artificial neural networks.

Environmental research·2021
Same author

Modeling and optimization of process parameters of biofilm reactor for wastewater treatment.

The Science of the total environment·2021
Same author

Prediction of batch sorption of barium and strontium from saline water.

Environmental research·2021
Same author

ZrO<sub>2</sub>-toughened Al<sub>2</sub>O<sub>3</sub>-based near-net shaped femoral head: Unique fabrication approach, 3D microstructure, burst strength and muscle cell response.

Materials science & engineering. C, Materials for biological applications·2017
Same author

Stability-indicating HPLC method for the determination of darunavir ethanolate.

Journal of chromatographic science·2012

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • DNA's large size and sequential nature present challenges for selective drug targeting.
  • Low molecular weight ligands binding to DNA can elicit diverse biological responses.
  • Developing sequence-selective DNA-binding agents is crucial for cancer diagnosis and treatment.

Purpose of the Study:

  • To review recent advancements in DNA sequence-selective binding agents.
  • To highlight agents with potential applications in cancer therapy and molecular biology.
  • To discuss novel conjugates and their DNA-binding and cytotoxic properties.

Main Methods:

  • Review of recent literature on DNA sequence-selective binding agents.
  • Discussion of cross-linked lexitropsin oligopeptides and hairpins.

Related Experiment Videos

  • Analysis of bis-distamycins, benzoyl nitrogen mustards, bis-benzimidazoles, and CBI/CPI conjugates.

    • Main Results:

    • Bis-distamycins and lexitropsins inhibit HIV integrases.
    • Benzoyl nitrogen mustard analogs show activity against tumor models.
    • Certain bis-benzimidazoles exhibit altered DNA sequence preference.
    • Adozelesin, bizelesin, and carzelesin demonstrate potent cytotoxicity.
    • CPI and CBI-lexitropsin conjugates exhibit femtomolar cytotoxicities.
    • PBD dimers show high cross-linking efficiency.

    Conclusions:

    • Novel DNA-binding agents offer significant potential for cancer treatment.
    • Sequence-selective binding agents are advancing the field of molecular biology.
    • Conjugates like PBD dimers and lexitropsins represent promising therapeutic strategies.